1. Home
  2. SCPH vs MVIS Comparison

SCPH vs MVIS Comparison

Compare SCPH & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • MVIS
  • Stock Information
  • Founded
  • SCPH 2013
  • MVIS 1993
  • Country
  • SCPH United States
  • MVIS United States
  • Employees
  • SCPH N/A
  • MVIS N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • SCPH Health Care
  • MVIS Technology
  • Exchange
  • SCPH Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • SCPH 299.0M
  • MVIS 274.2M
  • IPO Year
  • SCPH 2017
  • MVIS 1996
  • Fundamental
  • Price
  • SCPH $5.62
  • MVIS $1.14
  • Analyst Decision
  • SCPH Buy
  • MVIS Strong Buy
  • Analyst Count
  • SCPH 3
  • MVIS 3
  • Target Price
  • SCPH $12.00
  • MVIS $2.50
  • AVG Volume (30 Days)
  • SCPH 2.4M
  • MVIS 3.3M
  • Earning Date
  • SCPH 11-12-2025
  • MVIS 11-06-2025
  • Dividend Yield
  • SCPH N/A
  • MVIS N/A
  • EPS Growth
  • SCPH N/A
  • MVIS N/A
  • EPS
  • SCPH N/A
  • MVIS N/A
  • Revenue
  • SCPH $49,969,000.00
  • MVIS $2,584,000.00
  • Revenue This Year
  • SCPH $108.95
  • MVIS $47.70
  • Revenue Next Year
  • SCPH $78.30
  • MVIS $478.91
  • P/E Ratio
  • SCPH N/A
  • MVIS N/A
  • Revenue Growth
  • SCPH 107.79
  • MVIS N/A
  • 52 Week Low
  • SCPH $1.94
  • MVIS $0.80
  • 52 Week High
  • SCPH $6.28
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 52.96
  • MVIS 51.77
  • Support Level
  • SCPH N/A
  • MVIS N/A
  • Resistance Level
  • SCPH $5.62
  • MVIS $1.17
  • Average True Range (ATR)
  • SCPH 0.04
  • MVIS 0.05
  • MACD
  • SCPH -0.21
  • MVIS -0.04
  • Stochastic Oscillator
  • SCPH 99.56
  • MVIS 97.44

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: